TFA Therapeutics annual operating margin
2021
2022
2023
2024
2025
TFA Therapeutics's operating margin was −11.33% for fiscal 2025.
View full TFA Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −11.33% | +3.34 pp |
| 2024 | 2024-12-31 | −14.67% | −40.49 pp |
| 2023 | 2023-12-31 | 25.82% | +804.60 pp |
| 2022 | 2022-12-31 | −778.78% | −765.20 pp |
| 2021 | 2021-12-31 | −13.58% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Across the available reported history, TFA Therapeutics's operating margin increased from −14.67% to −11.33%, a change of +3.34 percentage points.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TFA Therapeutics filings at SEC.gov ↗